MARIA DELA ROSA: Open Payments
NPI 1013449206 · DUARTE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,195 in 62 payments from 17 companies in 2025. Trend: 2023 $26,820 · 2024 $11,052 · 2025 $7,195
Speaker / faculty: $4,050Food & beverage: $2,015Travel & lodging: $626Consulting: $275Education: $230
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $3,246 |
| AstraZeneca Pharmaceuticals LP | 16 | $2,696 |
| BeOne Medicines USA, Inc. | 12 | $391 |
| Incyte Corporation | 2 | $151 |
| Syndax Pharmaceuticals, Inc. | 1 | $130 |
| Lilly USA, LLC | 2 | $125 |
| Merck Sharp & Dohme LLC | 1 | $72 |
| BeiGene USA, Inc. | 2 | $64 |
| Genentech USA, Inc. | 2 | $56 |
| EMD Serono, Inc. | 1 | $56 |
Products named: VENCLEXTA, CALQUENCE, BRUKINSA, Monjuvi, IMBRUVICA, EPKINLY, KEYTRUDA, Vyloy.
Industry payments across CA — which companies pay providers there.
